Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumours

Journal of Comparative Pathology

Volumn 120, Issue 2, 1999, Pages 169-175

  Inoue, M ^a   Shiramizu, K ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN P53;

ADENOCARCINOMA; ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; BREAST TUMOR; CONTROLLED STUDY; DOG DISEASE; EPITHELIUM TUMOR; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABELING INDEX; MALIGNANT NEOPLASTIC DISEASE; MIXED TUMOR; MYOEPITHELIOMA; NONHUMAN; OSTEOSARCOMA;

ANIMALIA; CANIS FAMILIARIS;

EID: 0033067081     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcpa.1998.0268     Document Type: Article

References (30)

1. Andreassen A., Oyjord T., Hoving E., Holm R., Florenes V. A., Nesland J. M., Myklebost O., Hoie J., Bruland O. S., Borresen A. L., Fodstad O. p53 Abnormalities in different subtypes of human sarcoma. Cancer Research. 53:1993;468-471.
2. Baas I. O., Mulder J. W. R., Offerhaus J. A., Vogelstein B., Hamilton S. R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. Journal of Pathology. 172:1994;13-18.
3. Barnes D. M., Dublin E. A., Fisher C. J., Levison D. A., Millis R. R. Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Human Pathology. 24:1993;469-476.
4. Berns E., Klijn J. G., Putten W. L., Staveren I. L., Portengen H., Foekens J. A. c-myc Amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Research. 52:1992;1107-1113.
5. Cattoretti G., Rilke F., Andreola S., D'Amanto L., Delia D. p53 Expression in breast cancer. International Journal of Cancer. 41:1988;178-183.
6. Davidoff A. M., Humphrey P. A., Iglehart J. D., Marks J. R. Genetic basis for p53 overexpression in human breast cancer. Proceedings of the National Academy Sciences of the USA. 88:1991;5005-5010.
7. Dean M., Levine R. A., Ran W., Kindy M. S., Sonenshein G. E., Campisi J. Regulation of c-myc transcription mRNA abundance by serum growth factors and cell contact. Journal of Biological Chemistry. 261:1986;9161-9166.
8. Driouch K., Champeme M. H., Beuzelin M, Bieche I., Lidereau R. Classical gene amplifications in human breast cancer are not associated with distant solid metastases. British Journal of Cancer. 76:1997;784-787.
9. Field J. K., Spandidos D. A. The role of rats and myc oncogenes in human solid tumors and their relevance in diagnosis and prognosis. Anticancer Research. 10:1990;1-22.
10. Guerin M., Barrois M., Terrier M-J., Spielman M., Riou G. Overexpression of either c-myc or c-erbB-2 proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Research. 3:1988;21-31.
11. Iavarone A., Matthay K. K., Steinkirchner T. M., Israel M. A. Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma. Proceedings of the National Academy Sciences of the USA. 89:1992;4207-4209.
12. Iggo R., Gatter K., Bartek J., Lane D. P., Harris A. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet. 335:1990;675-679.
13. Iwaya K., Tsuda H., Hiraide H., Tamaki K., Tamakuma S., Fukutomi T., Mukai K., Hirohashi S. Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. Japanese Journal of Cancer Research. 82:1991;835-840.
14. Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Research. 51:1991;6304-6311.
15. Koutselini H., Malliri A., Field J. K., Spandidos D. A. p53 Expression in cytologic specimens from benign and malignant breast lesions. Anticancer Research. 11:1991;1415-1419.
16. Mazars R., Spinardi L., Ben Cheikh M., Simony-Lafontaine J., Jeanteur P., Theillet C. p53 Mutations occur in aggressive breast cancer. Cancer Research. 52:1992;3918-3923.
17. Miller C. W., Aslo A., Tsay C., Slamon D., Ishizaki K., Toguchida J., Yamamuro T., Lampin B., Koeffler H. P. Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Research. 50:1990;7950-7954.
18. Moulton J. E. Tumors of the mammary gland. InTumors in Domestic Animals. 1990;518-552.
19. Persons D. L., Borelli K. A., Hsu P. H. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization. Modern Pathology. 10:1997;720-727.
20. Sagartz J. E., Bodley W. L., Gamblin R. M., Couto C. G., Tierney L. A., Capen C. C. p53 Tumor suppressor protein overexpression in osteogenic tumors of dogs. Veterinary Pathology. 33:1996;213-221.
21. Spandidos D. A., Yiagnisis M., Papadimitriou K., Field J. K. ras, c-myc and c-erbB-2 Oncoproteins in human breast cancer. Anticancer Research. 9:1989;1385-1393.
22. Spencer C. A., Groudine M. Control of c-myc. Advances in Cancer Research. 56:1991;1-48.
23. Thor A. D., Moore D. H., Edgerton S. M., Kawasaki E. S., Reihsaus E., Lynch H. T., Marcus J. N, Schwartz L., Chen L. C., Mayall B. H., Smith H. S. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. Journal of the National Cancer Institute. 84:1992;845-855.
24. Ueda Y., Dockhorn-Dworniczak B., Blasius S., Mellin W., Wuisman P., Böcker W., Roessner A. Analysis of mutant p53 protein in osteosarcoma and other malignant and benign lesions of bone. Journal of Cancer Research and Clinical Oncology. 119:1993;172-178.
25. Van Leeuwen I. S., Hellmen E., Cornelisse C. J., Van den Burgh B., Rutteman G. R. p53 Mutations in mammary tumor cell lines and corresponding tumor tissues in the dog. Anticancer Research. 16:1996;3737-3744.
26. Varley J. M., Swallow J. E., Brammar W. J., Whittaker J. L., Walker R. A. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene. 1:1987;423-430.
27. Walker R. A., Dearing S. J., Lane D. P., Varley J. M. Expression of p53 protein in infiltrating and in-situ breast carcinomas. Journal of Pathology. 165:1991;203-211.
28. Walker R. A., Senior P. V., Jones J. L., Critchley D. R. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinoma. Journal of Pathology. 158:1989;97-105.
29. Watson P. H., Safneck J. R., Le K., Dubik D., Shiu R. P. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. Journal of the National Cancer Institute. 85:1993;902-907.
30. Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wilder-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 352:1991;345-347.